MBX2329
MBX2329, a potent influenza virus inhibitor, specifically inhibits hemagglutinin (HA) -mediated viral entry with HIV/HA (H5) displaying IC90 of 8.6 μM. MBX2329 inhibits a wide spectrum of influenza A viruses, which includes the 2009 pandemic influenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-resistant A/H1N1 strains[1].
Product Specifications
CAS Number
[1438272-42-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mbx2329.html
Purity
99.90
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CCC1=CC=CC=C1OCCN2CCCCCC2.[H]Cl
Molecular Formula
C16H26ClNO
Molecular Weight
283.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Basu A, et al. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol. 2014;88 (3) :1447-1460.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-131069A/MBX2329-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-131069A/MBX2329-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
